Journal
PHARMACEUTICAL RESEARCH
Volume 28, Issue 12, Pages 3016-3029Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-011-0550-2
Keywords
miRNA manipulation; miRNA therapeutics; oncomirs; tumor supressors
Funding
- National Breast Cancer Research Institute
- Health Research Board, Ireland
Ask authors/readers for more resources
MiRNAs are a class of small, naturally occurring RNA molecules that play critical roles in modulating numerous biological pathways by regulating gene expression. The knowledge that miRNA expression is dysregulated in many pathological disease processes, including cancer, has led to a rapidly expanding body of literature as we try to unveil their mechanism of action. Their putative role as oncogenes or tumour suppressor genes presents a wonderful opportunity to provide targeted cancer treatment strategies. Additionally, their documented function in a host of benign diseases broadens the potential market for miRNA-based therapeutics. The present review outlines the underlying rationales for considering mi(cro)RNAs as therapeutic agents or targets. We highlight the potential of manipulating miRNAs for the treatment of many common diseases, particularly cancers. Finally, we summarize the challenges that need to be overcome to fully harness the potential of miRNA-based therapies so they become the next generation of pharmaceutical products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available